Insmed Files Countersuit Against Tercica
A long-running battle over drugs for children with short stature took another turn Friday, when Insmed Inc. countersued rival pharmaceutical company Tercica Inc. for false advertising....To view the full article, register now.
Already a subscriber? Click here to view full article